Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis—A Safety Analysis

The incidence of AEs was low and comparable in patients receiving etrasimod with or without concomitant opioids or antidepressants. This analysis further supports the low likelihood of clinically relevant drug-drug interactions between etrasimod and medications commonly prescribed to patients with UC, such as opioids or antidepressants. (ClinicalTrials.gov: NCT03945188; NCT03996369).

Authors

Institutions

Publication Details

Journal
United European Gastroenterology Journal
Published
2025-02-01
DOI
https://doi.org/10.1002/ueg2.12745
Citations
1
Primary Topic
Eosinophilic Esophagitis
Type
article
Field-Weighted Citation Impact
2.01

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis—A Safety Analysis

Krisztina Lazin, Michael J. Keating, Anita Afzali, Andrés Yarur et al.
1 citations
United European Gastroenterology Journal
Eosinophilic Esophagitis
2.01
article

Concomitant Use of Etrasimod With Opioids or Antidepressants in Patients With Ulcerative Colitis—A Safety Analysis

Krisztina Lazin, Michael J. Keating, Anita Afzali, Andrés Yarur, Laurent Peyrin‐Biroulet, Siew C. Ng, Yamile Zabana, Diogo Branquinho, Miguel D. Regueiro, Eustratios Bananis, Abhishek Bhattacharjee, Aoibhinn McDonnell, Sujatha Menon
article en
1 citations

Abstract

The incidence of AEs was low and comparable in patients receiving etrasimod with or without concomitant opioids or antidepressants. This analysis further supports the low likelihood of clinically relevant drug-drug interactions between etrasimod and medications commonly prescribed to patients with UC, such as opioids or antidepressants. (ClinicalTrials.gov: NCT03945188; NCT03996369).

United European Gastroenterology JournalVol. 13(5)
Cedars-Sinai Medical Center (US), Cleveland Clinic (US), Inserm (FR), Chinese University of Hong Kong (HK), Pfizer (United States) (US), Pfizer (United Kingdom) (GB), Pfizer (Switzerland) (CH), Centre Hospitalier Régional et Universitaire de Nancy (FR), Mútua Terrassa (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Pfizer (India) (IN), Nutrition-Génétique et Exposition aux Risques Environnementaux (FR), Université de Lorraine (FR), University of Cincinnati Medical Center (US)
Pfizer
Good health and well-being
Openalex Percentile: Top 19%
Eosinophilic Esophagitis
2.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.